Detalles de la búsqueda
1.
AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial.
Clin Infect Dis
; 75(8): 1423-1432, 2022 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35147680
2.
Cytokines and chemokines differentially regulate innate immune cell trafficking during post kala-azar dermal leishmaniasis.
J Cell Biochem
; 119(9): 7406-7418, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29775225
3.
Comparative evaluation of PCR and imprint smear microscopy analyses of skin biopsy specimens in diagnosis of macular, papular, and mixed papulo-nodular lesions of post-kala-azar dermal leishmaniasis.
J Clin Microbiol
; 51(12): 4217-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24068017
4.
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
Lancet
; 377(9764): 477-86, 2011 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-21255828
5.
Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
Exp Parasitol
; 131(3): 274-82, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22580024
6.
Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
Clin Infect Dis
; 53(7): e91-8, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21890763
7.
Evaluation of qPCR on blood and skin microbiopsies, peripheral blood buffy coat smear, and urine antigen ELISA for diagnosis and test of cure for visceral leishmaniasis in HIV-coinfected patients in India: a prospective cohort study.
BMJ Open
; 11(4): e042519, 2021 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33931406
8.
A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis.
Indian J Dermatol Venereol Leprol
; 87(1): 34-41, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33580944
9.
False Positivity of rK39 Test in Five Chronic Myeloid Leukemia Cases from Bihar, India: A Possible Challenge to Leishmaniasis Diagnosis.
Am J Trop Med Hyg
; 103(6): 2257-2259, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32975180
10.
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India.
PLoS Negl Trop Dis
; 14(7): e0008429, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32687498
11.
Advanced case of PKDL due to delayed treatment: A rare case report.
PLoS Negl Trop Dis
; 14(3): e0008052, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32203500
12.
Identification of Clinical Immunological Determinants in Asymptomatic VL and Post Kala-azar Dermal Leishmaniasis Patients.
Iran J Parasitol
; 13(4): 541-548, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30697307
13.
Efficacy and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis in Children and Adolescents at a Tertiary Care Center in Bihar, India.
Am J Trop Med Hyg
; 97(5): 1498-1502, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29016288
14.
To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL).
PLoS One
; 12(3): e0174497, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28355259
15.
Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study.
PLoS Negl Trop Dis
; 10(10): e0005060, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27776123
16.
Nexus of infection with human immunodeficiency virus, pulmonary tuberculosis and visceral leishmaniasis: a case report from Bihar, India.
Am J Trop Med Hyg
; 72(1): 30-2, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15728863
17.
Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
Natl Med J India
; 18(3): 131-3, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16130613
18.
Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study.
Biomed Res Int
; 2015: 745062, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26090441
19.
Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study.
PLoS Negl Trop Dis
; 8(9): e3169, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25233346
20.
Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India.
PLoS Negl Trop Dis
; 8(1): e2536, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24392166